Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Natasa Djordjevic. (2022) Genotyping genetic variants of CYP2C19 for precision antiplatelet dosing: state of the art and future perspectives. Expert Opinion on Drug Metabolism & Toxicology 18:12, pages 817-830.
Read now
Read now
Aleksandra Kapedanovska-Nestorovska, Aleksandar J Dimovski, Zoran Sterjev, Nadica Matevska Geskovska, Ljubica Suturkova, Petar Ugurov, Zan Mitrev & Rodney Rosalia. (2019) The AKR1D1*36 (rs1872930) Allelic Variant Is Independently Associated With Clopidogrel Treatment Outcome. Pharmacogenomics and Personalized Medicine 12, pages 287-295.
Read now
Read now
Articles from other publishers (16)
Matteo CastrichiniJasmine A. Luzum & Naveen Pereira. (2023) Pharmacogenetics of Antiplatelet Therapy. Annual Review of Pharmacology and Toxicology 63:1, pages 211-229.
Crossref
Crossref
Suli Zhang, Jinhang Zhu, Hua Li, Fengzhen Li, Bin Zhu, Tao Li, Shuxin Fang & Shengying Qin. (2021) Associations of CYP2C19 and F2R genetic polymorphisms with platelet reactivity in Chinese ischemic stroke patients receiving clopidogrel therapy. Pharmacogenetics and Genomics 32:4, pages 138-143.
Crossref
Crossref
Grzegorz Procyk, Dominika Klimczak-Tomaniak, Grażyna Sygitowicz & Mariusz Tomaniak. (2022) Circulating and Platelet MicroRNAs in Cardiovascular Risk Assessment and Antiplatelet Therapy Monitoring. Journal of Clinical Medicine 11:7, pages 1763.
Crossref
Crossref
Travis J. O’Brien, Kevin Fenton, Alfateh Sidahmed, April Barbour & Arthur F. Harralson. (2021) Race and Drug Toxicity: A Study of Three Cardiovascular Drugs with Strong Pharmacogenetic Recommendations. Journal of Personalized Medicine 11:11, pages 1226.
Crossref
Crossref
Pamela Czajka, Alex Fitas, Daniel Jakubik, Ceren Eyileten, Aleksandra Gasecka, Zofia Wicik, Jolanta M. Siller-Matula, Krzysztof J. Filipiak & Marek Postula. (2021) MicroRNA as Potential Biomarkers of Platelet Function on Antiplatelet Therapy: A Review. Frontiers in Physiology 12.
Crossref
Crossref
Kong-Xiang Zhu, Pei-Yuan Song, He-Li, Mu-Peng Li, Yin-xiao Du, Qi-lin Ma, Li-Ming Peng & Xiao-Ping Chen. (2020) Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease. European Journal of Clinical Pharmacology 77:3, pages 359-368.
Crossref
Crossref
Jean-Sébastien Hulot, Bernard Chevalier, Loic Belle, Guillaume Cayla, Khalife Khalife, François Funck, Romain Berthier, Christophe Piot, Muriel Tafflet, Gilles Montalescot, Bernard Chevalier, Gilles Montalescot, Jean-Sébastien Hulot, Loïc Belle, Guillaume Cayla, Hervé Le Breton, Emmanuel Teiger, Grégoire Dambrin, K. Khalife, L. Schmutz, F. Funck, R. Berthier, C. Piot, G. Hannebicque, G. Montalescot, T. Lognone, F. De Poli, B. Chevalier, N. Lhoest, M. Schneeberger, N. Delarche, A. Faure, H. Aelion, M. Godin, M. Gilard, B. Ritz, P. Barraud, P. Barnay, L.N. Saïdi, O. Le Dref, P. Garot, G. Range, J. Georges, C. Robin, Y. Cottin, L. Belle, G. Souteyrand, A. Lafont, A. Fournier, P. Dupouy, P. Dupouy, J. Shayne, P. Chapon, C. Boureux, J.P. Faure, H. Ben Amer, A. Furber, O. Ormezzano, G. Bayet, G. Karrillon, L. Maillard, A. Grenzinger, A. Avran, R. Koning, D. Dumant, X. Lamit, R. Dauphin, L. Drogoul, T. Cuisset, O. Wittenberg, J.P. Peyre, P. Laury & R. Robert. (2020) Routine CYP2C19 Genotyping to Adjust Thienopyridine Treatment After Primary PCI for STEMI. JACC: Cardiovascular Interventions 13:5, pages 621-630.
Crossref
Crossref
Даниил Георгиевич Гительзон, Александр Георгиевич Файбушевич, Даниил Александрович Максимкин, Галина Ивановна Веретник, Владислав Юрьевич Баранович, Екатерина Александровна Гительзон, Александр Эдуардович Васильев & Карен Исмаилович Данишян. (2020) Персонализированная антитромботическая терапия при стентировании коронарных артерий. Естественные и Технические Науки:№10, pages 144-150.
Crossref
Crossref
Kunjie Li, Xingjie Guo, Feng Qin, Zhili Xiong, Longshan Zhao & Jia Yu. (2018) Identification of the cytochrome P450 enzymes involved in the oxidative metabolism of trantinterol using ultra high-performance liquid chromatography coupled with tandem mass spectrometry. RSC Advances 8:60, pages 34764-34772.
Crossref
Crossref
Francesca Wirth, Graziella Zahra, Robert G. Xuereb, Christopher Barbara, Liberato Camilleri, Albert Fenech & Lilian M. Azzopardi. (2018) CYP2C19*2 Allele Carrier Status and Coronary In-stent Restenosis: Is There an Association?. Journal of Exploratory Research in Pharmacology 3:2, pages 55-60.
Crossref
Crossref
Shangchen Xie, Wenjuan Ma, Qulian Guo, Jie Liu, Wei Li, Howard L McLeod & Yijing He. (2018) The pharmacogenetics of medications used in general anesthesia. Pharmacogenomics 19:3, pages 285-298.
Crossref
Crossref
Richard Myles Turner & Sir Munir Pirmohamed. 2018. Cardiovascular Genetics and Genomics. Cardiovascular Genetics and Genomics
119
172
.
Renata C. Costa de Freitas, Raul H. Bortolin, Mariana B. Lopes, Letícia Tamborlin, Letícia Meneguello, Vivian N. Silbiger, Rosario D. C. Hirata, Mário H. Hirata, Augusto D. Luchessi & André D. Luchessi. (2017) Modulation of miR-26a-5p and miR-15b-5p Exosomal Expression Associated with Clopidogrel-Induced Hepatotoxicity in HepG2 Cells. Frontiers in Pharmacology 8.
Crossref
Crossref
Jing Li, YueXi Wang & HuPing Wang. (2017) Distribution of CYP2C19 polymorphisms in Mongolian and Han nationals and the choice of specific antiplatelet drugs. International Journal of Clinical Pharmacy 39:4, pages 791-797.
Crossref
Crossref
SA Scott, J-P Collet, U Baber, Y Yang, I Peter, M Linderman, J Sload, W Qiao, AS Kini, SK Sharma, RJ Desnick, V Fuster, RJ Hajjar, G Montalescot & J-S Hulot. (2016)
Exome sequencing of extreme clopidogrel response phenotypes identifies
B4GALT2
as a determinant of on-treatment platelet reactivity
. Clinical Pharmacology & Therapeutics 100:3, pages 287-294.
Crossref
Crossref
Francesca Wirth, Graziella Zahra, Robert G. Xuereb, Christopher Barbara, Albert Fenech & Lilian M. Azzopardi. (2016) Comparison of a rapid point-of-care and two laboratory-based CYP2C19*2 genotyping assays for personalisation of antiplatelet therapy. International Journal of Clinical Pharmacy 38:2, pages 414-420.
Crossref
Crossref